Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update

Neoreviews. 2021 May;22(5):e284-e295. doi: 10.1542/neo.22-5-e1001.

Abstract

The coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept across the world like an indiscriminating wildfire. Pregnant women and neonates are particularly vulnerable to this infection compared with older children and healthy young adults, with unique challenges in their management. Unfamiliarity with the consequences of this novel virus and lack of high-quality data led to considerable heterogeneity in obstetrical and neonatal management early in the pandemic. The aim of the this review is to summarize the impact of SARS-CoV-2 infection on pregnancy and childbirth and to examine care and possible outcomes for neonates with Covid-19-positive mothers. A brief review of vaccines currently approved by the United States Food and Drug Administration for emergency use and their potential effects on pregnant and lactating women in included.

Publication types

  • Review

MeSH terms

  • Adult
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19* / prevention & control
  • COVID-19* / transmission
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases* / prevention & control
  • Infant, Newborn, Diseases* / therapy
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Pregnancy
  • Pregnancy Complications, Infectious* / drug therapy
  • Pregnancy Complications, Infectious* / prevention & control
  • Systemic Inflammatory Response Syndrome / drug therapy

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related